Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval
Thursday, January 5, 2017 - 14:01
in Health & Medicine
Spinraza, a “life-changing” drug for spinal muscular atrophy, will cost as much as $750,000 for the first year of treatment and $375,000 annually after that.